Effect of intravenous ketorolac and magnesium sulfate versus intravenous ketorolac and placebo on pain relief in patients with Colles' fracture

Effect of intravenous ketorolac and magnesium sulfate versus intravenous ketorolac and placebo on pain relief in patients with Colles' fracture: a double-blind randomized clinical trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N329

Enrollment

Registered

2019-12-30

Start date

2020-01-10

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colles' fracture. Colles' fracture

Interventions

Intervention 1: Intervention group: Intravenous ketorolac 30 mg single dose plus 100 ml normal saline including magnesium sulfate 50% 15 mg/kg as single dose. Intervention 2: Control group: Intravenou

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age of 18 to 65 years Colles' fracture

Exclusion criteria

Exclusion criteria: Unstable vital signs Neurovascular trauma Taking calcium or calcium antagonist Open fracture Local infection Narcotic addiction Cardiac arrhythmia Renal or liver failure Stomach ulcer Coagulopathy

Design outcomes

Primary

Measure	Time frame
The severity of pain. Timepoint: Before the intervention and 20, 40, and 60 minutes after the intervention. Method of measurement: Using Visual Analog Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Sajad Yavaribazl

Hamedan University of Medical Sciences

yavarybazl@gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026